http://www.prnewswire.com/news-releases/foxfire-and-foxfire-globa...

http://www.prnewswire.com/news-rele...ies-complete-patient-enrolment-290203621.html

'
SYDNEY, January 29, 2015 /PRNewswire/ --

Combined data from more than 1,000 patients being collected to assess overall survival (OS) benefit of adding first-line SIR-Spheres® Y-90 resin microspheres treatment to a current chemotherapy regimen for inoperable metastatic colorectal cancer (mCRC) ​

Sirtex Medical Limited (ASX:SRX) today announced the completion of patient enrolment in FOXFIRE and FOXFIRE Global, two large multi-centre studies that added liver-directed radiation therapy with SIR-Spheres Y-90 resin microspheres to a current standard of care chemotherapy regimen in the first-line treatment of more than 560 patients recently diagnosed with inoperable metastatic colorectal cancer (mCRC).' .................. etc